Enhanced viral hepatitis surveillance and prevention program

Active Cooperative Agreement Awarded Last action

Award ID
NU51PS005176
Recipient
Awarding agency
Obligated
$1,475,752

Award facts

Assistance listing
93.270 Viral Hepatitis Prevention and Control
Completion date 91% complete
Originally
Funding agency
National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
Burlington, VT, USA

Award details come from USAspending.gov.

Description

Abstract
The vermont department of health submits this project for consideration for CDC?s PS 21-2103: integrated viral hepatitis surveillance and prevention funding for health departments. The purpose of funding will be to address the priorities the CDC has set, of improving hepatitis surveillance, including outbreak control; facilitating state viral hepatitis elimination planning; and increasing access to hepatitis testing, prevention, vaccinations, syringe services programs, medically assisted treatment and treatment services. VDH proposes to address these priorities by targeting all funding to support the existing viral hepatitis staff position, embedded within the VDH?s HIV/aids, STD, viral hepatitis program. This position is an integral facet of VDH response to the syndemic of HIV, viral hepatitis and substance use disorder. The coordinator will spearhead efforts to continue to implement strategies and activities to attain the following required identified outcomes, detailed in the logic model provided in the notice of funding opportunity. Under component 1: core viral hepatitis outbreak response & surveillance, VDH will make progress in: ? Establishing a jurisdictional framework for outbreak detection and response in VT. ? Increasing public health reporting of chronic and perinatal HCV and chronic HBV infection in VT, and undetectable HCV RNA and HBV DNA laboratory results. ? Improving monitoring of VT?s burden of disease, trends, and outcomes in hepatitis a, acute hepatitis b and c, chronic hepatitis b and c, and perinatal hepatitis c. ? Improving monitoring of the hepatitis b and c continuums of cure (COC). ? Improving development and utilization of viral hepatitis surveillance data reports in VT. Under component 2: core viral hepatitis prevention, VDH will make progress in: ? Increasing engagement with VT?s key stakeholders in viral hepatitis elimination planning. ? Increasing commercial and hospital-based laboratories CON ducting HCV RNA reflex testing in VT. ? Increasing HCV and HBV testing in VT?s health care systems. ? Increasing utilization of ssps among pwid and referral of pwid to SUD treatment. ? Increasing receipt of hepatitis a and b vaccination among clients in high-impact settings. ? Increasing number of VT healthcare providers trained in prescribing hepatitis c and/or hepatitis b treatment. ? Increasing awareness of infection status among VT?s diagnosed with chronic hepatitis c and/or hepatitis b. ? Increased referral to treatment for vermonters living with hepatitis c and/or hepatitis b.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $223,487
Amendment $3,509
Amendment $0
Amendment $2,747
Amendment $0
Amendment $304,399
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $311,610
Amendment $3,390
Amendment $311,610
Amendment Enhanced viral hepatitis surveillance and prevention program - will conduct hepatitis prevention and surveillance. $0
Amendment $0
Amendment $0
Amendment $0
Amendment $3,395
Amendment $303,123
Original award $8,482
Show all 30

Subawards

Subrecipient Amount Awarded
Potter, Alexander HIV Prevention and Care $16,876
Potter, Alexander HIV Prevention and Care Services $40,500

Quick answers

Who received award NU51PS005176?

NU51PS005176 was awarded to Human Services Vermont Agency Of by Office of Financial Resources (Centers for Disease Control and Prevention) on May 1, 2021.

How much is award NU51PS005176 worth?

$1,475,752 has been obligated on NU51PS005176.

Which agency awarded NU51PS005176?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded NU51PS005176, with funding from National Center for Emerging and Zoonotic Infectious Diseases (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award